• Education
  • Points
  •  Download App
  • Country
    singapore
    hong kong
    malaysia
    indonesia
    thailand
    philippines
    vietnam
    india

    australia
    korea
    new zealand
The MIMS logo.
  • Home
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The MIMS logo.
  • Home
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The MIMS logo.
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates

Other Services
 Education
 Points
  Download App
Country
singapore
malaysia
indonesia
thailand
philippines
vietnam
india
australia
korea
new zealand
Account
The MIMS logo.
  1. Medical News & Updates
  2. List of Conferences
  3. ...
    • Medical News & Updates
    • List of Conferences
  4. Annual Meeting of The Endocrine Society (ENDO 2025)
Annual Meeting of The Endocrine Society (ENDO 2025)

Annual Meeting of The Endocrine Society (ENDO 2025)

San Francisco, California, US 12 July 2025 - 15 July 2025

GLP-1 drugs can raise testosterone levels in men
GLP-1 drugs can raise testosterone levels in men
15 hours ago byJairia Dela Cruz
Jairia Dela Cruz

The use of glucagon-like peptide 1 (GLP-1) drugs such as semaglutide, dulaglutide, and the dual agonist tirzepatide helps boost testosterone levels in men with obesity and type 2 diabetes (T2D), according to new research.

GLP-1 drugs can raise testosterone levels in men
15 hours ago
Intermittent energy restriction stands out for improving outcomes in people with T2D, obesity
Intermittent energy restriction stands out for improving outcomes in people with T2D, obesity
17 Aug 2025 byJairia Dela Cruz
Jairia Dela Cruz

In individuals with type 2 diabetes (T2D) and obesity, an intermittent energy restriction (IER) diet helps with glucose control, with the advantage of improving insulin sensitivity, reducing triglycerides, and being easier to follow compared with other dietary interventions, as shown in a single-centre randomized controlled trial.

Intermittent energy restriction stands out for improving outcomes in people with T2D, obesity
17 Aug 2025
The MIMS logo.
  • Drugs
  • Find Drugs
  • Pill Identifier
  • Find Drug Company
  • MIMS Abbreviation Index
  • Diseases
  • Search Disease Information
  • Medical News & Updates
  • Latest News & Updates
  • More Services
  • Education
  • Points
  • Subscribe
  • About
  • MIMS Corporate
  • Terms of Use
  • Privacy Policy
  • Feedback
Connect with MIMS
A social media brand icon.A social media brand icon.
TUV Nord ISO 9001 certification logo
MIMS Specialty v3.3.0
Copyright © 2025 MIMS Pte Ltd. All rights reserved. PRD
MIMS Logo

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?
Something went wrong.